Symbiotec Pharmalab IPO Review: A Niche Steroidal API Platform
Symbiotec Pharmalab combines leadership in steroidal APIs with complex injectables and biotech capabilities, offering global growth opportunities...
113 Views
Symbiotec Pharmalab Ltd (971073Z IN): Synthetic Expert Call Transcript (24 Aug 2026)
Niche Dominance vs. Growth Ceilings: Symbiotec Pharmalab holds a commanding 38.2% global volume share in corticosteroids and a 23.8% share in...
95 Views
Symbiotec Pharmalab IPO: Global Leadership in Niche APIs to Support Sustainable Growth
Symbiotec Pharmalab launches India IPO consisting of fresh issue of INR2B and OFS of INR16B. The price band is set at INR938–988. The IPO proceeds...
96 Views
Aequitas: Symbiotec Pharmalab Ltd Pre-IPO Tearsheet
Symbiotec Pharmalab Ltd (SPL) is looking to raise about US$244m in its upcoming India IPO. The deal will be run by Avendus, JM Fin, Nomura and...
322 Views
Aequitas ECM Weekly (26 January 2026)- Busy Ming, Montage, Eastroc, Muyuan, Longcheer, Sinotruk,
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
266 Views
No more insights